Novo Nordisk reports a significant reduction in obesity rates among children aged 6 to under 12 treated with semaglutide in a ...

Novartis India has announced the acquisition of Pfizer's hypertension drug Minipress for ₹1250 crore, aiming to enhance its ...

Piyush Goyal calls for regulatory alignment with developed countries to boost investment and innovation in India's ...

RPG Life Sciences plans to invest Rs 500 crore over the next year to enhance its manufacturing and Active Pharmaceutical ...

Medical experts caution consumers about the use of experimental injectable peptides for weight loss and anti-aging, ...

The European Medicines Agency reviews injectable iron medicines due to concerns about low phosphate levels and potential bone ...

Fosun Pharma reduces its stake in Gland Pharma, selling 4.5% through block deals on BSE, attracting several major investors ...

New Delhi: More than 60% of the 8,500 registered small and medium pharmaceutical units in India may be forced to shut shop by the end of this month for failing to comply with the guidelines on good ...

Cipla has entered a licensing agreement to market Qil2107, a biosimilar of Keytruda in the US. The partnership aims to ...

India's drug regulator has flagged a batch of the widely used rabies vaccine Abhayrab as substandard, prompting ...

Novartis' experimental heart drug pelacarsen missed key goals in a late-stage trial, leading to a significant drop in shares ...

Novartis India is set to enhance its growth strategy with therapy-aligned acquisitions while expanding its reach in Tier 2 ...